A GCIG Intergroup multicentre trial of open label carboplatin and paclitaxel +/- bevacizumab compared with oxaliplatin and capecitabine +/- bevacizumab as first line chemotherapy in patients with mucinous Epithelial Ovarian Cancer.
Trial Number
ISRCTN83438782 (ISRCTN Registry)Contact Person
Status
Completed
Disease Site
Ovarian